BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29540995)

  • 1. The Many Facets of Sphingolipids in the Specific Phases of Acute Inflammatory Response.
    Grösch S; Alessenko AV; Albi E
    Mediators Inflamm; 2018; 2018():5378284. PubMed ID: 29540995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
    Norris GH; Blesso CN
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29143791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory response and its relation to sphingolipid metabolism proteins: Chaperones as potential indirect anti-inflammatory agents.
    Yagci ZB; Esvap E; Ozkara HA; Ulgen KO; Olmez EO
    Adv Protein Chem Struct Biol; 2019; 114():153-219. PubMed ID: 30635081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sphingolipids in drug metabolism and transport.
    Kim YM; Park TS; Kim SG
    Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):319-31. PubMed ID: 23289866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids and their metabolism in physiology and disease.
    Hannun YA; Obeid LM
    Nat Rev Mol Cell Biol; 2018 Mar; 19(3):175-191. PubMed ID: 29165427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular facets of sphingolipids: mediators of diseases.
    Ozbayraktar FB; Ulgen KO
    Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces.
    Abdel Hadi L; Di Vito C; Riboni L
    Mediators Inflamm; 2016; 2016():3827684. PubMed ID: 26880864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational aspects of sphingolipid metabolism.
    Zeidan YH; Hannun YA
    Trends Mol Med; 2007 Aug; 13(8):327-36. PubMed ID: 17588815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipid metabolism and interorganellar transport: localization of sphingolipid enzymes and lipid transfer proteins.
    Yamaji T; Hanada K
    Traffic; 2015 Feb; 16(2):101-22. PubMed ID: 25382749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipid-Transporting Proteins as Cancer Therapeutic Targets.
    Samaha D; Hamdo HH; Wilde M; Prause K; Arenz C
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipids inhibit vimentin-dependent cell migration.
    Hyder CL; Kemppainen K; Isoniemi KO; Imanishi SY; Goto H; Inagaki M; Fazeli E; Eriksson JE; Törnquist K
    J Cell Sci; 2015 Jun; 128(11):2057-69. PubMed ID: 25908861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection.
    Chiricozzi E; Loberto N; Schiumarini D; Samarani M; Mancini G; Tamanini A; Lippi G; Dechecchi MC; Bassi R; Giussani P; Aureli M
    J Leukoc Biol; 2018 Mar; 103(3):445-456. PubMed ID: 29345379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the role of the Target of Rapamycin signaling in sphingolipid metabolism.
    Teixeira V; Costa V
    Prog Lipid Res; 2016 Jan; 61():109-33. PubMed ID: 26703187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sphingolipid and apoptosis].
    Wang J; Hu XS; Shi JP
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):217-21. PubMed ID: 14628466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational Aspects of Sphingolipid Metabolism in Renal Disorders.
    Abou Daher A; El Jalkh T; Eid AA; Fornoni A; Marples B; Zeidan YH
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipid homeostasis in the web of metabolic routes.
    Aguilera-Romero A; Gehin C; Riezman H
    Biochim Biophys Acta; 2014 May; 1841(5):647-56. PubMed ID: 24184514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid metabolites in neural signalling and function.
    Colombaioni L; Garcia-Gil M
    Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation.
    Olesch C; Ringel C; Brüne B; Weigert A
    Mediators Inflamm; 2017; 2017():6059203. PubMed ID: 28848247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional roles of sphingolipids in immunity and their implication in disease.
    Lee M; Lee SY; Bae YS
    Exp Mol Med; 2023 Jun; 55(6):1110-1130. PubMed ID: 37258585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipids and mitochondrial apoptosis.
    Patwardhan GA; Beverly LJ; Siskind LJ
    J Bioenerg Biomembr; 2016 Apr; 48(2):153-68. PubMed ID: 25620271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.